Yunnan Botanee Bio-Technology Group (300957.SZ) plans to invest 50 million yuan in the JinYu Fund to target multiple medical-related fields.

Yunnan Botanee Bio-Technology Group (300957.SZ) announced that the company recently signed the "Wuxi Jinyu Mao Medical Health Industry Investment Partnership Enterprise (limited partnership) Partnership Agreement". Jinyu Fund is managed by Jinyu Mao Investment Management Co., Ltd. As one of the limited partners of Jinyu Fund, the company will use its own funds to subscribe for a capital contribution of 50 million yuan. After this investment is completed, the company will hold a 5% partnership stake in Jinyu Fund. It is reported that the partnership enterprise will mainly invest in consumer healthcare and national health quality improvement (including health care, medical beauty, special medical and functional food, etc.), drugs (including synthetic biology, innovative drugs, etc.), medical equipment, medical supportive industries, AI pharmaceuticals, and other fields.